Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

Published:2015-03 Issue:3 Volume:135 Page:925
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Saini Sarbjit S.,Bindslev-Jensen Carsten,Maurer Marcus,Grob Jean-Jacques,Bülbül Baskan Emel,Bradley Mary S.,Canvin Janice,Rahmaoui Abdelkader,Georgiou Panayiotis,Alpan Oral,Spector Sheldon,Rosén Karin

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?;World Allergy Organization Journal;2024-08

2. Chronic Spontaneous Urticaria;Immunology and Allergy Clinics of North America;2024-08

3. Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment;The Lancet;2024-07

4. Temporal, Drug Dose, and Sample Size Trends in the Efficacy of Omalizumab for Chronic Spontaneous Urticaria: A Cumulative Meta‐Analysis;Journal of Clinical Pharmacy and Therapeutics;2024-01

5. Chronic spontaneous urticaria;The Rose and Mackay Textbook of Autoimmune Diseases;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP